Latest

The moving edge of the record

Outcomes just published, the agenda for the next meeting, and recommended drugs still waiting for a PBS listing. All from pbs.gov.au, updated as the source documents appear.

Just decided

3 meetings · short post-meeting outcomes

From the PBAC's short post-meeting outcomes summary. The full Public Summary Documents follow ~6–8 weeks later; items move into the record as each PSD lands.

July 2026 PBAC Meeting

10 Jul 2026 · 60 items · source

Drug	Indication	Outcome
AcalabrutinibCalquence®	First-line treatment of Stage III or IV mantle cell lymphoma in patients ineligible for st…	Recommended
AfliberceptEydenzelt®	Subfoveal choroidal neovascularisation due to age-related macular degeneration, diabetic m…	Recommended
Agalsidase Alfa And Agalsidase BetaReplagal®, Fabrazyme®	Treatment of Fabry disease	Recommended
Amino Acid Formula With Vitamins And Minerals Without Lysine And Low In TryptophanGA1 Anamix Infant®, GA1 Anamix Junior®	Dietary management of pyridoxine-dependent epilepsy deficiency	Recommended
Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine And IsoleucineMSUD Anamix Infant®, MSUD Anamix Junior®, MSUD Lophlex LQ 20®, MSUD Maxamum®	Dietary management of short-chain enoyl CoA hydratase 1 and 3-hydroxyisobutyryl Co-A hydro…	Recommended
Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine And IsoleucineMSUD express 15®	Dietary management of short-chain enoyl CoA hydratase 1 and 3-hydroxyisobutyryl Co-A hydro…	Recommended
Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine, Isoleucine And Supplemented With Arachidonic Acid And Docosahexaenoic AcidMSUD explore5®	Dietary management of short-chain enoyl CoA hydratase 1 and 3-hydroxyisobutyryl Co-A hydro…	Recommended
AmivantamabRybrevant SC®	First-line and second-line treatment of non-small cell lung cancer with EGFR exon 20 inser…	Recommended
AnifrolumabSaphnelo®	Treatment of severe systemic lupus erythematosus with persistent disease activity despite …	Recommended
Apadamtase Alfa With Cinaxadamtase Alfa (Recombinant Adamts13)Adzynma®	Treatment of chronic, severe congenital thrombotic thrombocytopenia purpura	Recommended
AtezolizumabTecentriq SC®	Multiple cancer indications	Withdrawn
AzacitidineAzacitidine Accord®, Azacitidine Dr Reddy's®, Azacitidine Euglia®, Azacitidine Juno®, Azacitidine MSN®, Azacitidine Sandoz®, Azacitidine SXP®	Acute myeloid leukemia, myelodysplastic syndrome, chronic myelomonocytic leukemia	Noted
Belantamab MafodotinBlenrep®	Relapsed and/or refractory multiple myeloma after at least one prior line of therapy	Recommended
Bempedoic Acid And Bempedoic Acid With EzetimibeNexletol®, Nexlizet®	Hypercholesterolaemia in patients at high cardiovascular risk with statin intolerance or m…	Not recommended
Birch TriterpenesFilsuvez®	Partial thickness wounds associated with dystrophic or junctional epidermolysis bullosa	Not recommended
BlinatumomabBlincyto®	Acute lymphoblastic leukaemia and precursor B-cell acute lymphoblastic leukaemia	Recommended
Brentuximab VedotinAdcetris®	First-line treatment of advanced stage CD30 positive Hodgkin lymphoma	Recommended
BrivaracetamBriviact®	Intractable focal onset seizures	Noted
ClozapineClozaril®, Clozaril ODT®	Schizophrenia in patients non-responsive to or unable to tolerate other antipsychotic medi…	Recommended
DaratumumabDarzalex SC®	Newly diagnosed systemic light chain amyloidosis, untreated multiple myeloma, relapsed and…	Noted
DelgocitinibAnzupgo®	Moderate to severe chronic hand eczema where topical corticosteroids failed or are medical…	Not recommended
DepemokimabExdensur®	Uncontrolled severe eosinophilic asthma in patients aged 12 years or older	Recommended
DonidalorsenZirdawny®	Long-term prophylaxis of recurrent attacks of hereditary angioedema	Recommended
DupilumabDupixent®	Chronic severe atopic dermatitis in children aged 6 months to 11 years	Not recommended
ElacestrantOrserdu®	Estrogen receptor-positive, human epidermal growth factor receptor 2-negative locally adva…	Not recommended
Elexacaftor With Tezacaftor And With Ivacaftor, And IvacaftorTrikafta®	Cystic fibrosis in patients aged 6-11 years weighing less than 30 kg	Recommended
EltrombopagRevolade®	Severe aplastic anaemia and severe thrombocytopenia	Recommended
EpcoritamabEpkinly®	Relapsed or refractory diffuse large B-cell lymphoma	Withdrawn
Estradiol With ProgesteroneBijuva®	Vasomotor symptoms in post-menopausal women	Recommended
EtonogestrelImplanon NXT®	Contraception	Not recommended
EvolocumabRepatha®	Homozygous familial hypercholesterolaemia, heterozygous familial hypercholesterolaemia, no…	Recommended
FinerenoneKerendia®	Symptomatic heart failure with left ventricular ejection fraction greater than or equal to…	Not recommended
GuselkumabTremfya®	Severe Crohn disease in patients who failed prior systemic therapy	Recommended
Loncastuximab TesirineZynlonta®	Diffuse large B-cell lymphoma in patients with relapsed or refractory disease after two or…	Recommended
MethoxsalenUvadex®	Cutaneous T-cell lymphoma and chronic graft-versus-host disease	Recommended
Mifepristone And MisoprostolMS-2 Step®	Termination of intra-uterine pregnancy	Recommended
OdevixibatBylvay®	Cholestatic pruritus in Alagille syndrome	Recommended
Onasemnogene AbeparvovecOAV101 IT®	Spinal muscular atrophy in patients aged 2-19 years with signs and symptoms prior to 3 yea…	Recommended
PegcetacoplanEmpaveli®	Complement 3 glomerulopathy and primary immune complex membranoproliferative glomeruloneph…	Recommended
PegvaliasePalynziq®	Phenylketonuria in patients aged 16 years and older with inadequate blood phenylalanine co…	Recommended
PegzilarginaseLoargys®	Arginase 1 deficiency in patients aged 2 years or older	Noted
PirtobrutinibJaypirca®	Chronic lymphocytic leukaemia and small lymphocytic lymphoma	Noted
ProgesteroneUtrogestan®	Unexplained threatened miscarriage in first trimester with vaginal bleeding and history of…	Recommended
Sebelipase AlfaKanuma®	Late-onset lysosomal acid lipase deficiency	Not recommended
TeplizumabTzield®	Type 1 diabetes Stage 2 in patients aged 8 years or older	Not recommended
TeprotumumabTepezza®	Active, moderate-to-severe thyroid eye disease	Recommended
TislelizumabTevimbra®	Advanced or metastatic gastro-oesophageal cancer	Noted
UstekinumabSteqeyma®	Severe chronic plaque psoriasis, severe psoriatic arthritis, severe Crohn disease, complex…	Recommended
UstekinumabYesintek®	Severe chronic plaque psoriasis, severe psoriatic arthritis, severe Crohn disease, complex…	Recommended
VutrisiranAmvuttra®	Transthyretin amyloid cardiomyopathy with New York Heart Association Class I or II disease	Recommended
AzithromycinVarious brands	Diphtheria	Recommended
Designated Registered Nurse Prescribing	Various indications	Recommended
High Clinical Unmet Need And High Added Therapeutic Value Project Update		Noted
Increase Maximum Amounts For Cetuximab, Doxorubicin, Fluorouracil, Ifosfamide, Infliximab, Rituximab And Tocilizumab	Various	Noted
Pbac Guidelines And Streamlined Assessment Project Update		Noted
LanreotideSomatuline Autogel®, Mytolac®, LACREO®	Acromegaly, functional carcinoid tumour, non-functional gastroenteropancreatic neuroendocr…	Recommended
Tranche 3 – Review Of Pbs Prescriber Bag (Levonorgestrel, Ulipristal, Mifepristone And Misoprostol, Prednisolone, Corticosteroid Tablets, Naloxone, Oxytocin, Midazolam)	Various indications	Noted
ApalutamideErlyand®	Treatment of metastatic castration-resistant prostate cancer and metastatic hormone-sensit…	Recommended
Levodopa With Carbidopa And EntacaponeLecigon®	Advanced idiopathic Parkinson disease with severe motor fluctuations	Recommended
ProgesteroneUtrogestan®	IVF program as part of assisted reproductive technology treatment cycle	Recommended

May 2026 PBAC Meeting

2026-05-01 · 8 items · source

Drug	Indication	Outcome
Adalimumab And Infliximab	Paediatric moderate to severe Crohn disease and ulcerative colitis	Recommended
FedratinibInrebic®	Myelofibrosis	Recommended
MigalistatGalafold®	Fabry disease	Noted
RanibizumabSusvimo®	Neovascular age-related macular degeneration	Not recommended
Raxtozinameran (Bnt162b2-Platform Covid-19 Vaccine)Comirnaty®	Prevention of coronavirus disease 2019 caused by SARS-CoV-2	Recommended
Respiratory Syncytial Virus VaccinemResvia®	Prevention of lower respiratory tract disease caused by RSV in individuals aged over 75 ye…	Deferred
TarlatamabImdelltra®	Extensive-stage small cell lung cancer with progression on or after first-line platinum-ba…	Noted
TucatinibTUKYSA®	Metastatic HER2-positive breast cancer	Noted

March 2026 PBAC Meeting

2026-03-01 · 12 items · source

Drug	Indication	Outcome
Adrenaline (Epinephrine)Neffy®	Acute severe allergic reactions in children and adults at significant risk of anaphylaxis	Recommended
BurosumabCrysvita®	Tumour induced osteomalacia (TIO) with hypophosphataemia	Recommended
EdaravoneRadicava®	Amyotrophic lateral sclerosis (ALS)	Recommended
EnoxaparinClexane® Safety-Lock, Clexane® Forte Safety-Lock	Prevention and treatment of thromboembolic disorders, haemodialysis	Withdrawn
Glycomacropeptide Formula With Docosahexaenoic Acid And Low PhenylalaninePKU GMPro® Delight	Phenylketonuria (PKU)	Recommended
Multicomponent Meningococcal Group B VaccineBexsero®	Prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis group …	Noted
Respiratory Syncytial Virus VaccineArexvy®	Prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV)	Recommended
Sars-Cov-2 MrnaSpikevax®	Prevention of coronavirus disease 2019 (COVID-19)	Not Applicable
TacrolimusaZematop®	Atopic dermatitis	Recommended
Erythropoietin Stimulating Agents, Iron Chelating Agents, Bulevirtide	Various	Noted
Preservative-Free Ocular Lubricants	Severe dry eye disease	Noted
Designated Registered Nurse Prescribing Medicines	Various	Noted

Coming up

cycle briefing

November 2026 PBAC Meeting

6 Nov 2026 · 17 on the agenda · source

Drug	Indication	Purpose
AcoramidisAttruby®	Transthyretin amyloid cardiomyopathy (ATTR-CM)	List acoramidis for treatment of ATTR-CM with NYHA class I-II heart failure at i…
AfliberceptEylea®	Branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) with macula…	List 8 mg strength for treatment of visual impairment due to macular oedema seco…
AumolertinibVelarion®	Non-small cell lung cancer (NSCLC)	List aumolertinib for first and second-line treatment of Stage IIIB/IV NSCLC wit…
BaxdrostatBaxfendy®	Hypertension	List baxdrostat for treatment of uncontrolled and resistant hypertension despite…
CannabidiolEpidyolex®	Seizures associated with tuberous sclerosis complex (TSC)	List cannabidiol as add-on therapy for drug-resistant epilepsy in TSC patients.
ClesrovimabEnflonsia®	Prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV)	List clesrovimab for RSV prevention in young infants and children up to 24 month…
Datopotamab DeruxtecanDatroway®	Breast cancer	List datopotamab deruxtecan for first-line treatment of metastatic triple-negati…
DrospirenoneSlindelle®	Contraception and endometriosis-associated pelvic pain (EAPP)	List drospirenone for contraception and management of EAPP.
Efgartigimod AlfaVyvgart®	Chronic inflammatory demyelinating polyneuropathy (CIDP)	Resubmission to list efgartigimod alfa for CIDP in patients with ongoing disabil…
Enfortumab VedotinPADCEV®	Muscle-invasive bladder cancer (MIBC)	List enfortumab vedotin with pembrolizumab for perioperative treatment of non-me…
EpcoritamabEpkinly®	Relapsed or refractory (R/R) follicular lymphoma (FL)	List epcoritamab with rituximab and lenalidomide for R/R FL after one or more pr…
IvosidenibTibsovo®	Acute myeloid leukaemia (AML)	List ivosidenib for newly diagnosed IDH1-mutation positive AML ineligible for in…
MetreleptinMyalepta®	Lipodystrophy	List metreleptin for leptin-deficient lipodystrophy with uncontrolled metabolic …
Mifepristone And MisoprostolMS-2 Step®	Management of miscarriage	List mifepristone and misoprostol for management of missed miscarriage up to 70 …
NerandomilastJascayd®	Idiopathic pulmonary fibrosis (IPF)	List nerandomilast for treatment-naïve IPF or after nintedanib/pirfenidone disco…
NerandomilastJascayd®	Progressive pulmonary fibrosis (PPF)	List nerandomilast for treatment-naïve PPF or after nintedanib discontinuation.
NusinersenSpinraza®	Spinal muscular atrophy (SMA)	List two new strengths of nusinersen for SMA populations currently eligible.

Awaiting listing

200 recommendations awaiting a listing, across 155 medicines

A positive PBAC recommendation is not a listing — pricing and listing arrangements come after. These have a “yes” but no PBS subsidy yet; the wait is counted from the meeting date, as at 28 Aug 2026. The unit is the recommendation, not the medicine: a drug recommended for several indications appears once per indication.

Drug	Indication	PBAC meeting	Waiting
AfliberceptEydenzelt®	Branch retinal vein occlusion with macular oedema; Central retinal vein occlusion …	Jul 2026	51 days
DupilumabDupixent®	Chronic severe atopic dermatitis	Jul 2026	51 days
DelgocitinibAnzupgo®	Chronic hand eczema (CHE)	Jul 2026	51 days
TeprotumumabTepezza®	Thyroid eye disease (TED)	Jul 2026	51 days
GuselkumabTremfya®	Severe Crohn disease (CD)	Jul 2026	51 days
Estradiol With ProgesteroneBijuva®	Vasomotor symptoms in post-menopausal women	Jul 2026	51 days
AcalabrutinibCalquence®	Mantle cell lymphoma (MCL)	Jul 2026	51 days
FedratinibInrebic®	Myelofibrosis (MF)	May 2026	112 days
UstekinumabArdelya®	Severe chronic plaque psoriasis Severe psoriatic arthritis	Mar 2026	170 days
Avacincaptad PegolIzervay®	Geographic atrophy (GA) secondary to age-related macular degeneration (AMD)	Mar 2026	170 days
CanakinumabIlaris®	Colchicine-resistant or intolerant Familial Mediterranean Fever (crFMF)	Mar 2026	170 days
DupilumabDupixent®	Chronic obstructive pulmonary disease (COPD)	Mar 2026	170 days
LanreotideLacreo	Acromegaly Functional carcinoid tumour Non-functional gastroenteropancreatic neuroendocrin…	Mar 2026	170 days
Glycomacropeptide Formula With Docosahexaenoic Acid And Low PhenylalaninePKU GMPro® Delight	Phenylketonuria (PKU)	Mar 2026	170 days
DurvalumabImfinzi®	Gastric cancer (GC) or gastro-oesophageal junction cancer (GOJC)	Mar 2026	170 days
AdalimumabYuflyma®	Moderate to severe ulcerative colitis Severe juvenile idiopathic arthritis Severe …	Mar 2026	170 days
AsciminibScemblix®	Chronic myeloid leukaemia (CML)	Mar 2026	170 days
Efgartigimod AlfaVyvgart®	Generalised myasthenia gravis (gMG)	Mar 2026	170 days
ObinutuzumabGazyva®	Lupus nephritis	Mar 2026	170 days
UpadacitinibRinvoq®	Fistulising Crohn’s disease (FCD)	Mar 2026	170 days
RisperidoneUzedy®	Schizophrenia	Mar 2026	170 days
TeclistamabTecvayli®	Relapsed or refractory multiple myeloma (RRMM)	Mar 2026	170 days
NemolizumabNemluvio®	Atopic dermatitis	Mar 2026	170 days
MepolizumabNucala®	Chronic obstructive pulmonary disease (COPD)	Mar 2026	170 days
EnzalutamideXtandi®	Non-metastatic hormone sensitive prostate cancer (nmHSPC)	Mar 2026	170 days
AmivantamabRybrevant®	Non-small cell lung cancer (NSCLC)	Mar 2026	170 days
AdalimumabAmgevita®	Crohn disease Ulcerative colitis Active juvenile idiopathic arthritis Complex refractory …	Mar 2026	170 days
RuxolitinibJakavi®	Myelofibrosis Graft versus host disease Polycythemia vera	Mar 2026	170 days
CannabidiolEpidyolex®	Severe myoclonic epilepsy in infancy (Dravet syndrome)	Mar 2026	170 days
IncobotulinumtoxinaXeomin®	Moderate to severe spasticity of the lower limb in adults following an acute event	Mar 2026	170 days
OmalizumabOmlyclo®	Uncontrolled severe asthma Uncontrolled severe allergic asthma Severe chronic spontaneous …	Mar 2026	170 days
NivolumabOpdivo®	Malignant melanoma Non-Small Cell Lung Cancer (NSCLC) Renal Cell Carcinoma (RCC) Squamous …	Mar 2026	170 days
CiclosporinVevye®	Dry eye disease with keratitis	Mar 2026	170 days
TofersenQalsody®	Amyotrophic lateral sclerosis (ALS)	Mar 2026	170 days
TirzepatideMounjaro® Mounjaro® KwikPen®	Type 2 diabetes mellitus	Mar 2026	170 days
RetifanlimabZynyz®	Merkel cell carcinoma (MCC)	Mar 2026	170 days
TacrolimusaZematop®	Atopic dermatitis	Mar 2026	170 days
RetifanlimabZynyz®	Squamous cell anal carcinoma (SCAC)	Mar 2026	170 days
PembrolizumabKeytruda	Advanced and metastatic cancers	Dec 2025	261 days
Velmanase AlfaLamzede®	Alpha-mannosidosis	Dec 2025	261 days
SeladelparLivdelzi®	Primary biliary cholangitis (PBC)	Dec 2025	261 days
FenfluramineFintepla®	Lennox-Gastaut Syndrome (LGS)	Nov 2025	296 days
Encorafenib BinimetinibBraftovi® Mektovi®	Non-small cell lung cancer (NSCLC)	Nov 2025	296 days
Onasemnogene AbeparvovecZolgensma®	Spinal muscular atrophy (SMA)	Nov 2025	296 days
CetrorelixFemvi®	Assisted Reproductive Technology (ART)	Nov 2025	296 days
Efgartigimod AlfaVyvgart®	Generalised myasthenia gravis (gMG)	Nov 2025	296 days
OmaveloxoloneSkyclarys®	Friedreich’s ataxia	Nov 2025	296 days
TucatinibTukysa®	Breast cancer	Nov 2025	296 days
ZanubrutinibBrukinsa®	Mantle cell lymphoma (MCL) Waldenstrom macroglobulinaemia (WM) Chronic lymphocytic …	Nov 2025	296 days
AfliberceptEydenzelt®	Subfoveal choroidal neovascularisation (CNV) due to pathologic myopia (PM)	Nov 2025	296 days
SemaglutideWegovy®	Established cardiovascular disease (eCVD) with obesity	Nov 2025	296 days
Estradiol With ProgesteroneBijuva®	Vasomotor symptoms in post menopausal women	Nov 2025	296 days
FezolinetantVeoza®	Moderate to severe menopause-related vasomotor symptoms (VMS)	Nov 2025	296 days
TocilizumabAvtozma®	Severe active juvenile idiopathic arthritis Severe active rheumatoid arthritis Systemic …	Nov 2025	296 days
DelgocitinibAnzupgo®	Chronic hand eczema (CHE)	Nov 2025	296 days
Mirvetuximab SoravtansineElahere®	Epithelial ovarian, fallopian tube or primary peritoneal cancer	Nov 2025	296 days
ZolbetuximabVyloy®	Gastric or gastroesophageal junction (G/GOJ) cancer	Sep 2025	357 days
LeniolisibJoenja®	Activated PI3K delta syndrome (APDS)	Jul 2025	415 days
AcalabrutinibCalquence®	Mantle cell lymphoma	Jul 2025	415 days
GuselkumabTremfya®	Severe Crohn disease	Jul 2025	415 days
PaliperidonePaljuna Monthly	Schizophrenia	Jul 2025	415 days
TacrolimusaZematop®	Atopic dermatitis	Jul 2025	415 days
BulevirtideHepcludex®	Chronic hepatitis D	Jul 2025	415 days
Triglycerides, Medium ChainMCT Oil	Chylous ascites Chylothorax Fat malabsorption Hyperlipoproteinaemia type 1 Intractable chi…	Jul 2025	415 days
Triglycerides - Medium Chain, FormulaMonogen®	Dietary management of conditions requiring a source of medium chain triglycerides Hyperlip…	Jul 2025	415 days
GuselkumabTremfya®	Chronic plaque psoriasis (CPP)	May 2025	476 days
OmalizumabXolair®	Chronic rhinosinusitis with nasal polyps (CRSwNP)	May 2025	476 days
TeprotumumabTepezza®	Thyroid Eye Disease (TED)	May 2025	476 days
NatalizumabTyruko®	Relapsing-remitting multiple sclerosis (RRMS)	Mar 2025	534 days
UstekinumabEpyztek®	Severe chronic plaque psoriasis Severe psoriatic arthritis Severe Crohn disease Complex …	Mar 2025	534 days
MidostaurinRydapt®	Advanced systemic mastocytosis	Mar 2025	534 days
MogamulizumabPoteligeo®	Cutaneous T-cell lymphoma (CTCL)	Mar 2025	534 days
Efgartigimod AlfaVyvgart®	Generalised myasthenia gravis (gMG)	Mar 2025	534 days
Polatuzumab VedotinPolivy®	Diffuse large B-cell lymphoma (DLBCL)	Mar 2025	534 days
GemcitabineGemcitabine Sandoz®	Various cancers	Mar 2025	534 days
ToripalimabZytorvi®	Nasopharyngeal carcinoma	Mar 2025	534 days
AbrocitinibCibinqo®	Severe atopic dermatitis	Nov 2024	660 days
LanadelumabTakhzyro®	Hereditary angioedema (HAE)	Nov 2024	660 days
LeuprorelinEligard®	Central precocious puberty Locally advanced (stage C) or metastatic (stage D) carcinoma …	Nov 2024	660 days
OlaparibLynparza®	Metastatic castration-resistant prostate cancer (mCRPC)	Nov 2024	660 days
ErenumabAimovig®	Chronic migraine	Nov 2024	660 days
Enfortumab VedotinPadcev®	Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer (la/mUC)	Nov 2024	660 days
BudesonideBudenofalk®	Ulcerative colitis	Nov 2024	660 days
RivaroxabanXarelto®	Prevention of venous thromboembolism Chronic stable atherosclerotic disease	Nov 2024	660 days
Triglycerides, Long Chain With Glucose PolymerProZero®	Proven inborn errors of protein metabolism	Nov 2024	660 days
ProgesteroneUtrogestan®	Luteal phase support	Jul 2024	779 days
Milk Powder -- SyntheticLocasol®	Hypercalcaemia	Jul 2024	779 days
ApalutamideErlyand®	Non-metastatic castration-resistant carcinoma of the prostate Metastatic castration-sensit…	Jul 2024	779 days
Drospirenone With EthinylestradiolYaz®; Yasmin®	Oral contraceptive Moderate acne vulgaris in women who seek oral contraception Premenstrua…	Jul 2024	779 days
Levodopa With Carbidopa And EntacaponeLecigon®	Advanced Parkinson disease	Jul 2024	779 days
Amino Acid Formula With Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids Without PhenylalaninePKU Start	Phenylketonuria	Mar 2024	898 days
LebrikizumabEbglyss®	Atopic dermatitis	Mar 2024	898 days
Sodium Zirconium CyclosilicateLokelma®	Chronic hyperkalaemia	Mar 2024	898 days
TofacitinibXeljanz® XR	Rheumatoid arthritis Psoriatic arthritis	Mar 2024	898 days
Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty AcidsNeocate® Syneo	Cows' milk protein enteropathy Severe cows' milk protein enteropathy with failure …	Mar 2024	898 days
CabozantinibCabometyx®	Advanced clear cell variant renal cell carcinoma in combination with nivolumab	Mar 2024	898 days
UstekinumabStelara®	Psoriatic arthritis Crohn disease Chronic plaque psoriasis Ulcerative colitis Fistulising …	Mar 2024	898 days
PembrolizumabKeytruda®	Squamous cell carcinoma (SCC)	Nov 2023	1031 days
LenacapavirSunlenca®	Human immunodeficiency virus (HIV)	Nov 2023	1031 days
Pneumococcal Conjugate Vaccine, 20-ValentPrevenar 20®	Prevention of pneumococcal disease	Nov 2023	1031 days
Meningococcal VaccineMenveo®	Prevention of invasive meningococcal diseases (IMDs)	Nov 2023	1031 days
Varicella Zoster Virus Recombinant VaccineShingrix®	Herpes zoster virus	Nov 2023	1031 days
CabotegravirApretude®	Pre-exposure prophylaxis of HIV infection	Sep 2023	1092 days
MirikizumabOmvoh®	Moderate to severe ulcerative colitis (MUSC)	Jul 2023	1150 days
MobocertinibExkivity®	Locally advanced or metastatic non-small cell lung cancer (NSCLC)	Jul 2023	1150 days
Relatlimab And NivolumabOpdualag®	Melanoma	Jul 2023	1150 days
Trastuzumab DeruxtecanEnhertu®		Jul 2023	1150 days
Varicella Zoster Virus Recombinant VaccineShingrix®	Prevention of herpes zoster and post-herpetic neuralgia	Jul 2023	1150 days
Carmellose With Glycerol And Hyaluronic AcidOptive Fusion®	Severe dry eye syndrome	May 2023	1211 days
Hyaluronic Acid With Polyethylene Glycol 400 With Propylene Glycol With Hydroxypropyl GuarSystane® Hydration	Severe dry eye syndrome	May 2023	1211 days
AlirocumabPraluent®	Familial heterozygous hypercholesterolaemia and non-familial hypercholesterolaemia.	Mar 2023	1269 days
BudesonideJorveza®	Eosinophilic oesophagitis	Mar 2023	1269 days
Glycomacropeptide And Essential Amino Acids With Vitamins And MineralsTylactin RTD	Tyrosinaemia	Mar 2023	1269 days
RomosozumabEvenity®	Osteoporosis	Mar 2023	1269 days
AbemaciclibVerzenio™	Breast cancer	Mar 2023	1269 days
Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty AcidsEleCare® LCP	Cows' milk protein enteropathy; Severe cows' milk protein enteropathy with failure …	Mar 2023	1269 days
High Fat Formula With Vitamins, Minerals And Trace Elements And Low In Protein And CarbohydrateKetoVie 3:1 KetoVie 4:1 KetoVie Peptide 4:1	Ketogenic diet	Mar 2023	1269 days
Pneumococcal Conjugate Vaccine, 15 Valent AdsorbedVaxneuvance®	Prevention of pneumococcal disease	Mar 2023	1269 days
Varicella Zoster Virus Recombinant VaccineShingrix®	Prevention of herpes zoster and post-herpetic neuralgia	Mar 2023	1269 days
InfliximabRemsima® SC	Rheumatoid arthritis	Nov 2022	1395 days
Amino Acid Formula With Vitamins And Minerals Without PhenylalaninePKU Squeezie®	Phenylketonuria	Nov 2022	1395 days
Budesonide With Glycopyrronium And FormoterolBreztri Aerosphere® DFP-EvoCap	Chronic obstructive pulmonary disease	Nov 2022	1395 days
Elexacaftor With Tezacaftor And With Ivacaftor, And IvacaftorTrikafta®	Cystic fibrosis	Nov 2022	1395 days
MidazolamZyamis®	Epilepsy	Nov 2022	1395 days
RisankizumabSkyrizi®	Crohn Disease	Nov 2022	1395 days
UstekinumabStelara®	Severe Crohn disease Severe chronic plaque psoriasis	Jul 2022	1514 days
ProgesteroneCyclogest®	Infertility	Jul 2022	1514 days
Human Menopausal GonadotrophinMenopur® 600 Menopur® 1200	Assisted Reproductive Technology	Jul 2022	1514 days
TrientineCuprior®	Wilson disease	May 2022	1575 days
DulaglutideTrulicity®	Type 2 diabetes mellitus	May 2022	1575 days
PembrolizumabKeytruda®	Gastro-oesophageal cancers	May 2022	1575 days
FremanezumabAjovy®	Chronic migraine	Mar 2022	1633 days
SomapacitanSogroya®	Adult growth hormone deficiency	Mar 2022	1633 days
Beclometasone With FormoterolFostair®	Chronic obstructive pulmonary disease	Mar 2022	1633 days
BimekizumabBimzelx®	Plaque psoriasis	Mar 2022	1633 days
RabeprazolePariet®	Complex gastro-oesophageal reflux disease; Scleroderma oesophagus; Gastro-oesophageal …	Mar 2022	1633 days
OzanimodZeposia®	Ulcerative colitis	Mar 2022	1633 days
DupilumabDupixent®	Atopic dermatitis	Mar 2022	1633 days
Diptheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis And Haemophilus Influenzae Type B Conjugate Vaccine (Dtap-Hb-Ipv-Hib)Vaxelis®	Diptheria; tetanus; pertussis; hepatitis B; poliomyelitis and Haemophilus influenzae …	Mar 2022	1633 days
SecukinumabCosentyx®	Paediatric psoriasis	Nov 2021	1759 days
AdalimumabHulio®	Severe Crohn disease; Moderate to severe ulcerative colitis; Severe active juvenile …	Nov 2021	1759 days
EtanerceptRymti®	Rheumatoid arthritis; Plaque psoriasis; Ankylosing spondylitis; Psoriatic arthritis; …	Nov 2021	1759 days
Insulin AspartTruvelog®; Truvelog® Solostar	Diabetes mellitus	Nov 2021	1759 days
RisankizumabSkyrizi®	Severe chronic plaque psoriasis	Nov 2021	1759 days
IxekizumabTaltz®	Non radiographic axial spondyloarthritis (nr-axSpA)	Nov 2021	1759 days
MelatoninSlenyto®	Insomnia	Nov 2021	1759 days
Pneumococcal Polysaccharide Conjugate Vaccine, 15 Valent AdsorbedTrade name to be confirmed	Prevention of pneumococcal disease	Nov 2021	1759 days
Amino Acid Formula With Vitamins And Minerals Without PhenylalaninePKU express 15®	Phenylketonuria	Jul 2021	1878 days
HydrocortisoneAlkindi®	Adrenal Insufficiency	Jul 2021	1878 days
Amino Acid Formula With Vitamins And Minerals Without MethionineHCU express 15®	Pyridoxine non-responsive homocystinuria	Jul 2021	1878 days
Amino Acid Formula With Vitamins And Minerals Without Phenylalanine And TyrosineTYR express 15®	Tyrosinaemia	Jul 2021	1878 days
Amino Acid Formula With Vitamins And Minerals Without PhenylalaninePKU express 20®	Phenylketonuria	Jul 2021	1878 days
Amino Acid Formula With Vitamins And Minerals Without Valine, Leucine And IsoleucineMSUD express 15®	Maple syrup urine disease	Jul 2021	1878 days
BortezomibDBL Bortezomib®	Multiple Myeloma	Jul 2021	1878 days
NivolumabOpdivo®	Second-line squamous cell oesophageal carcinoma (2L OSCC)	Jul 2021	1878 days
Elexacaftor + Tezacaftor + IvacaftorTrikafta®	Cystic fibrosis	Jul 2021	1878 days
EvolocumabRepatha®	Familial heterozygous hypercholesterolaemia; Non-familial hypercholesterolaemia; Familial …	Mar 2021	1997 days
High Fat Formula With Vitamins, Minerals And Trace Elements And Low In Protein And CarbohydrateKetoCal 3:1® KetoCal 4:1®	Ketogenic Diet	Mar 2021	1997 days
AvelumabBavencio®	Urothelial carcinoma	Mar 2021	1997 days
AvelumabBavencio®	Renal cell carcinoma (RCC)	Mar 2021	1997 days
BevacizumabMvasi®	Metastatic colorectal cancer Epithelial ovarian, fallopian tube, or primary peritoneal …	Nov 2020	2123 days
TofacitinibXeljanz®	Chronic plaque psoriasis Psoriatic arthritis Rheumatoid arthritis Ulcerative arthritis	Nov 2020	2123 days
Vitamins, Minerals And Trace Elements With CarbohydratePaediatric Seravit®	Dietary management of conditions requiring a highly restrictive therapeutic diet	Jul 2020	2242 days
Carbohydrate, Fat, Vitamins, Minerals And Trace ElementsEnergivit®	Proven inborn errors of protein metabolism	Jul 2020	2242 days
Milk Powder Synthetic Low CalciumLocasol®	Hypercalcaemia	Jul 2020	2242 days
Fosnetupitant (As Chloride Hydrochloride)/Palonosetron (As Hydrochloride)AKYNZEO IV®	Nausea and vomiting	Jul 2020	2242 days
GuselkumabTremfya®	Severe chronic plaque psoriasis	Jul 2020	2242 days
Triglycerides Medium Chain FormulaMonogen®	Dietary management of conditions requiring a source of medium chain triglycerides, …	Jul 2020	2242 days
Whey Protein Formula Supplemented With Amino Acids, Vitamins And Minerals, And Low In Protein, Phosphate, Potassium And LactoseKindergen®	Chronic Renal Failure (CRF)	Jul 2020	2242 days
BevacizumabZirabev®	Advanced International Federation of Gynecology and Obstetrics (FIGO) Stage IIIB, …	Jul 2020	2242 days
Amino Acid Formula With Vitamins, Minerals And Long Chain Polyunsaturated Fatty Acids Without Phenylalanine; Amino Acid Formula With Vitamins And Minerals Without Phenylalanine And Tyrosine; Amino Acid Formula With Vitamins And Minerals Without LysinAnamix Infant® Formulas	Phenylketonuria (PKU); Tyrosinaemia (TYR); Glutaric Aciduria Type 1; Methylmalonic …	Jul 2020	2242 days
FulvestrantFaslodex®	Breast cancer	Jul 2020	2242 days
EnoxaparinEnoxapo®	Prevention and treatment of deep vein thrombosis; haemodialysis	Jul 2020	2242 days
BimatoprostVizo-PF Bimatoprost®	Reduction of elevated intraocular pressure or open angle glaucoma, as first line therapy …	Jul 2020	2242 days
Fluocinolone AcetonideIluvien®	Diabetic macular oedema	Mar 2020	2361 days
Triglycerides Medium Chain FormulaLipistart®	Dietary management of conditions requiring a source of medium chain triglycerides	Mar 2020	2361 days
DupilumabDupixent®	Atopic dermatitis	Mar 2020	2361 days
Whey Protein Formula Supplemented With Amino Acids, Long Chain Polyunsaturated Fatty Acids, Vitamins And Minerals, Low In Protein, Phosphate, Potassium And LactoseRenastart®	Chronic kidney disease (CKD)	Mar 2020	2361 days
Milk Protein And Fat Formula With Vitamins And Minerals Carbohydrate FreeCarbohydrate Free Mix®	Ketogenic diet	Mar 2020	2361 days
Amino Acid Synthetic Formula Supplemented With Long Chain Polyunsaturated Fatty Acids Amino Acid Formula Supplemented With Prebiotics, Probiotics And Long Chain Polyunsaturated Fatty AcidsNeocate LCP® Neocate Syneo®	Cow’s milk allergy, multiple food intolerance and other medical conditions where an …	Mar 2020	2361 days
Triglycerides Medium Chain And Long Chain With Glucose PolymerDuocal®	Proven inborn errors of protein metabolism	Mar 2020	2361 days
Glycomacropeptide And Essential Amino Acids With Vitamins And MineralsPKU Build® 10; PKU Build® 20	Phenylketonuria	Nov 2019	2487 days
Dimethyl FumarateTecfidera®	Relapsing-remitting multiple sclerosis (RRMS)	Nov 2019	2487 days
BrivaracetamBriviact®	Epilepsy	Nov 2019	2487 days
Amino Acid Formula With Vitamins With Minerals, Without Valine, Leucine And Isoleucine With Docosohexaenoic Acid And Arachidonic AcidMSUD explore®	Maple syrup urine disease	Nov 2019	2487 days
Tezacaftor With IvacaftorSymdeko®	Cystic Fibrosis (CF)	Nov 2019	2487 days
IbrutinibImbruvica®	Chronic lymphocytic leukaemia (CLL); small lymphocytic lymphoma (SLL)	Nov 2019	2487 days
Protein Formula With Vitamins And Minerals, And Low In Potassium, Phosphorus, Calcium, Chloride And Vitamin ARenastep®	Chronic kidney disease (CKD)	Nov 2019	2487 days
SemaglutideOzempic®	Type 2 diabetes mellitus (T2DM)	Nov 2019	2487 days
GalcanezumabEmgality®	Chronic migraine	Jul 2019	2606 days
Fluticasone FuroateArnuity Ellipta®	Asthma	Jul 2019	2606 days
CemiplimabLibtayo®	Cervical cancer	—	—
Daunorubicin With CytarabineVyxeos®	Acute myeloid leukaemia	—	—
PegcetacoplanSyfovre®	Bilateral geographic atrophy (GA) secondary to age-related macular degeneration (AMD)	—	—
ZolbetuximabVyloy®	Gastric or gastroesophageal junction (G/GOJ) cancer	—	—
SemaglutideWegovy®	Established atherosclerotic cardiovascular disease (eASCVD) with obesity	—	—
LeniolisibJoenja®	Activated PI3K delta syndrome (APDS)	—	—
AdalimumabAmgevita®	Immune-mediated inflammatory disease	—	—
FremanezumabAjovy®	Treatment-resistant migraine	—	—
Avacincaptad PegolIzervay®	Geographic atrophy (GA) secondary to age-related macular degeneration (AMD)	—	—